Tyszko, M.; Lipińska-Gediga, M.; Lemańska-Perek, A.; Kobylińska, K.; Gozdzik, W.; Adamik, B.
Intestinal Fatty Acid Binding Protein (I-FABP) as a Prognostic Marker in Critically Ill COVID-19 Patients. Pathogens 2022, 11, 1526.
https://doi.org/10.3390/pathogens11121526
AMA Style
Tyszko M, Lipińska-Gediga M, Lemańska-Perek A, Kobylińska K, Gozdzik W, Adamik B.
Intestinal Fatty Acid Binding Protein (I-FABP) as a Prognostic Marker in Critically Ill COVID-19 Patients. Pathogens. 2022; 11(12):1526.
https://doi.org/10.3390/pathogens11121526
Chicago/Turabian Style
Tyszko, Maciej, Małgorzata Lipińska-Gediga, Anna Lemańska-Perek, Katarzyna Kobylińska, Waldemar Gozdzik, and Barbara Adamik.
2022. "Intestinal Fatty Acid Binding Protein (I-FABP) as a Prognostic Marker in Critically Ill COVID-19 Patients" Pathogens 11, no. 12: 1526.
https://doi.org/10.3390/pathogens11121526
APA Style
Tyszko, M., Lipińska-Gediga, M., Lemańska-Perek, A., Kobylińska, K., Gozdzik, W., & Adamik, B.
(2022). Intestinal Fatty Acid Binding Protein (I-FABP) as a Prognostic Marker in Critically Ill COVID-19 Patients. Pathogens, 11(12), 1526.
https://doi.org/10.3390/pathogens11121526